Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Applied Molecular Transport Inc.
Report date December 27, 2023 · Filed December 29, 2023
Jointly reported with EPIQ Capital Group, LLC, Boeding Chad, EPQ LLC AMT PS, EPQ LLC, AMTC PS
Section 16 reporting ended · disclosed 2023-12-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Last balance in matching sequence
After 2023-12-27 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2023-12-27 · Other · Disposed 2,149,292 · Balance 6,188,226 F1: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. F2: EPQ LLC, AMT PS is the direct owner of these shares. F6: Upon consummation of the Merger, EPQ LLC, AMT PS received Transaction Consideration of 286,071 shares of Cyclo common stock. F10: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. Row 2 · 2023-12-27 · Other · Disposed 3,394,948 · Balance 2,793,278 F1: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. F3: EPQ LLC, AMTB PS is the direct owner of these shares. F7: Upon consummation of the Merger, EPQ LLC, AMTB PS received Transaction Consideration of 451,868 shares of Cyclo common stock. F10: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. Row 3 · 2023-12-27 · Other · Disposed 2,500,000 · Balance 293,278 F1: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. F4: EPQ LLC, AMTC PS is the direct owner of these shares. F8: Upon consummation of the Merger, EPQ LLC, AMTC PS received Transaction Consideration of 332,750 shares of Cyclo common stock. F10: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. Row 4 · 2023-12-27 · Other · Disposed 293,278 · Balance 0 F1: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. F5: Chad Boeding is the owner of these shares through a trust that he controls. F9: Upon consummation of the Merger, Chad Boeding received Transaction Consideration of 39,036 shares of Cyclo common stock. F10: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger.
F2: EPQ LLC, AMT PS is the direct owner of these shares.
F3: EPQ LLC, AMTB PS is the direct owner of these shares.
F4: EPQ LLC, AMTC PS is the direct owner of these shares.
F5: Chad Boeding is the owner of these shares through a trust that he controls.
F6: Upon consummation of the Merger, EPQ LLC, AMT PS received Transaction Consideration of 286,071 shares of Cyclo common stock.
F7: Upon consummation of the Merger, EPQ LLC, AMTB PS received Transaction Consideration of 451,868 shares of Cyclo common stock.
F8: Upon consummation of the Merger, EPQ LLC, AMTC PS received Transaction Consideration of 332,750 shares of Cyclo common stock.
F9: Upon consummation of the Merger, Chad Boeding received Transaction Consideration of 39,036 shares of Cyclo common stock.
F10: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 27, 2023 Filed Dec 29, 2023 17:40 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | OtherCommon Stock | 293,278 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001667731-23-000513 · ownership.xml · nonDerivative · entry 4 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% Owner Boeding Chad · CIK 0001779451 · CEO of Managing Member EPQ LLC AMT PS · CIK 0001751796 · Owner EPQ LLC, AMTB PS · CIK 0001788890 · owner EPQ LLC, AMTC PS · CIK 0001814486 · owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. F5 · shares: Chad Boeding is the owner of these shares through a trust that he controls. F9 · price: Upon consummation of the Merger, Chad Boeding received Transaction Consideration of 39,036 shares of Cyclo common stock. F10 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 17:40 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | OtherCommon Stock | 2,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001667731-23-000513 · ownership.xml · nonDerivative · entry 3 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% Owner Boeding Chad · CIK 0001779451 · CEO of Managing Member EPQ LLC AMT PS · CIK 0001751796 · Owner EPQ LLC, AMTB PS · CIK 0001788890 · owner EPQ LLC, AMTC PS · CIK 0001814486 · owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 293,278 F1 · kind: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. F4 · shares: EPQ LLC, AMTC PS is the direct owner of these shares. F8 · price: Upon consummation of the Merger, EPQ LLC, AMTC PS received Transaction Consideration of 332,750 shares of Cyclo common stock. F10 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 17:40 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | OtherCommon Stock | 3,394,948 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001667731-23-000513 · ownership.xml · nonDerivative · entry 2 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% Owner Boeding Chad · CIK 0001779451 · CEO of Managing Member EPQ LLC AMT PS · CIK 0001751796 · Owner EPQ LLC, AMTB PS · CIK 0001788890 · owner EPQ LLC, AMTC PS · CIK 0001814486 · owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,793,278 F1 · kind: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. F3 · shares: EPQ LLC, AMTB PS is the direct owner of these shares. F7 · price: Upon consummation of the Merger, EPQ LLC, AMTB PS received Transaction Consideration of 451,868 shares of Cyclo common stock. F10 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 17:40 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | OtherCommon Stock | 2,149,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001667731-23-000513 · ownership.xml · nonDerivative · entry 1 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% Owner Boeding Chad · CIK 0001779451 · CEO of Managing Member EPQ LLC AMT PS · CIK 0001751796 · Owner EPQ LLC, AMTB PS · CIK 0001788890 · owner EPQ LLC, AMTC PS · CIK 0001814486 · owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,188,226 F1 · kind: On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. F2 · shares: EPQ LLC, AMT PS is the direct owner of these shares. F6 · price: Upon consummation of the Merger, EPQ LLC, AMT PS received Transaction Consideration of 286,071 shares of Cyclo common stock. F10 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. Read SEC document |
| May 13, 2022 Filed May 16, 2022 17:49 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | PurchaseCommon Stock | 29,763 | $4.17 | $124,123.62 |
DisclosureSEC source: 0001667731-22-000196 · s202205epiqamti.xml · nonDerivative · entry 2 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% Owner EPQ LLC AMT PS · CIK 0001751796 · Owner EPQ LLC, AMTB PS · CIK 0001788890 · Owner EPQ LLC, AMTC PS · CIK 0001814486 · Owner Boeding Chad · CIK 0001779451 · CEO of Managing Member Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 8,337,518 F1 · ownership.nature: Chad Boeding acquired the shares listed in column 4 through a trust that he controls. F2 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding owns 293,278 common shares through a trust that he controls. Read SEC document |
| May 12, 2022 Filed May 16, 2022 17:49 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | PurchaseCommon Stock | 32,380 | $3.88 | $125,634.40 |
DisclosureSEC source: 0001667731-22-000196 · s202205epiqamti.xml · nonDerivative · entry 1 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% Owner EPQ LLC AMT PS · CIK 0001751796 · Owner EPQ LLC, AMTB PS · CIK 0001788890 · Owner EPQ LLC, AMTC PS · CIK 0001814486 · Owner Boeding Chad · CIK 0001779451 · CEO of Managing Member Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 8,307,755 F1 · ownership.nature: Chad Boeding acquired the shares listed in column 4 through a trust that he controls. F2 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding owns 293,278 common shares through a trust that he controls. Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 15:41 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | PurchaseCommon Stock | 7,135 | $22.38 | $159,684.15 |
DisclosureSEC source: 0001667731-21-000314 · ownership.xml · nonDerivative · entry 2 EPIQ Capital Group, LLC · CIK 0001779453 · Managing member of 10% owner EPQ LLC AMT PS · CIK 0001751796 · Owner EPQ LLC, AMTB PS · CIK 0001788890 · 10% owner EPQ LLC, AMTC PS · CIK 0001814486 · Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 8,275,375 F1 · ownership.nature: Chad Boeding acquired these shares through a trust that he controls. F2 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding owns 231,135 common shares through a trust that he controls. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 15:41 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | PurchaseCommon Stock | 4,000 | $22.57 | $90,298.40 |
DisclosureSEC source: 0001667731-21-000314 · ownership.xml · nonDerivative · entry 1 EPIQ Capital Group, LLC · CIK 0001779453 · Managing member of 10% owner EPQ LLC AMT PS · CIK 0001751796 · Owner EPQ LLC, AMTB PS · CIK 0001788890 · 10% owner EPQ LLC, AMTC PS · CIK 0001814486 · Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 8,268,240 F1 · ownership.nature: Chad Boeding acquired these shares through a trust that he controls. F2 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding owns 231,135 common shares through a trust that he controls. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 17:55 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | ConversionSeries C Preferred Stock · Derivative | 3,394,948 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001779453-20-000004 · primary_doc.xml · derivative · entry 6 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% owner EPQ LLC AMT PS · CIK 0001751796 · See footnote 7 EPQ LLC, AMTB PS · CIK 0001788890 · 10% owner EPQ LLC, AMTC PS · CIK 0001814486 · See footnote 7 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 3,394,948 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Automatic conversion of Series C Preferred stock held by EPQ LLC, AMTB PS to Common Stock in connection with the initial public offering of the Issuer. F2 · shares: Automatic conversion of Series C Preferred stock held by EPQ LLC, AMTB PS to Common Stock in connection with the initial public offering of the Issuer. F2 · price: Automatic conversion of Series C Preferred stock held by EPQ LLC, AMTB PS to Common Stock in connection with the initial public offering of the Issuer. F2 · derivative.exercise_date: Automatic conversion of Series C Preferred stock held by EPQ LLC, AMTB PS to Common Stock in connection with the initial public offering of the Issuer. F2 · derivative.expiration_date: Automatic conversion of Series C Preferred stock held by EPQ LLC, AMTB PS to Common Stock in connection with the initial public offering of the Issuer. F4 · ownership.nature: EPQ LLC, AMTB PS is the direct owner of these shares. F7 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding directly owns 220,000 common shares. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 17:55 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | ConversionSeries B Preferred Stock · Derivative | 2,149,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001779453-20-000004 · primary_doc.xml · derivative · entry 5 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% owner EPQ LLC AMT PS · CIK 0001751796 · See footnote 7 EPQ LLC, AMTB PS · CIK 0001788890 · 10% owner EPQ LLC, AMTC PS · CIK 0001814486 · See footnote 7 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 2,149,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Automatic conversion of Series B Preferred stock held by EPQ LLC, AMT PS to Common Stock in connection with the initial public offering of the Issuer. F1 · shares: Automatic conversion of Series B Preferred stock held by EPQ LLC, AMT PS to Common Stock in connection with the initial public offering of the Issuer. F1 · price: Automatic conversion of Series B Preferred stock held by EPQ LLC, AMT PS to Common Stock in connection with the initial public offering of the Issuer. F1 · derivative.exercise_date: Automatic conversion of Series B Preferred stock held by EPQ LLC, AMT PS to Common Stock in connection with the initial public offering of the Issuer. F1 · derivative.expiration_date: Automatic conversion of Series B Preferred stock held by EPQ LLC, AMT PS to Common Stock in connection with the initial public offering of the Issuer. F3 · ownership.nature: EPQ LLC, AMT PS is the direct owner of these shares. F7 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding directly owns 220,000 common shares. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 17:55 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | PurchaseCommon Stock | 220,000 | $14.00 | $3,080,000.00 |
DisclosureSEC source: 0001779453-20-000004 · primary_doc.xml · nonDerivative · entry 4 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% owner EPQ LLC AMT PS · CIK 0001751796 · See footnote 7 EPQ LLC, AMTB PS · CIK 0001788890 · 10% owner EPQ LLC, AMTC PS · CIK 0001814486 · See footnote 7 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,264,240 F6 · shares: Chad Boeding is the direct owner of these shares. F7 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding directly owns 220,000 common shares. F8 · ownership.nature: Each of EPIQ, the EPQ Funds, and Mr. Boeding disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 17:55 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | PurchaseCommon Stock | 2,500,000 | $14.00 | $35,000,000.00 |
DisclosureSEC source: 0001779453-20-000004 · primary_doc.xml · nonDerivative · entry 3 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% owner EPQ LLC AMT PS · CIK 0001751796 · See footnote 7 EPQ LLC, AMTB PS · CIK 0001788890 · 10% owner EPQ LLC, AMTC PS · CIK 0001814486 · See footnote 7 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,044,240 F5 · shares: EPQ LLC, AMTC PS is the direct owner of these shares. F7 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding directly owns 220,000 common shares. F8 · ownership.nature: Each of EPIQ, the EPQ Funds, and Mr. Boeding disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 17:55 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | ConversionCommon Stock | 3,394,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001779453-20-000004 · primary_doc.xml · nonDerivative · entry 2 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% owner EPQ LLC AMT PS · CIK 0001751796 · See footnote 7 EPQ LLC, AMTB PS · CIK 0001788890 · 10% owner EPQ LLC, AMTC PS · CIK 0001814486 · See footnote 7 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,544,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Automatic conversion of Series C Preferred stock held by EPQ LLC, AMTB PS to Common Stock in connection with the initial public offering of the Issuer. F4 · shares: EPQ LLC, AMTB PS is the direct owner of these shares. F7 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding directly owns 220,000 common shares. F8 · ownership.nature: Each of EPIQ, the EPQ Funds, and Mr. Boeding disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 17:55 UTC | Applied Molecular Transport Inc. AMTI · Entity 95737 | ConversionCommon Stock | 2,149,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001779453-20-000004 · primary_doc.xml · nonDerivative · entry 1 EPIQ Capital Group, LLC · CIK 0001779453 · Managing Member of 10% owner EPQ LLC AMT PS · CIK 0001751796 · See footnote 7 EPQ LLC, AMTB PS · CIK 0001788890 · 10% owner EPQ LLC, AMTC PS · CIK 0001814486 · See footnote 7 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,149,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Automatic conversion of Series B Preferred stock held by EPQ LLC, AMT PS to Common Stock in connection with the initial public offering of the Issuer. F3 · shares: EPQ LLC, AMT PS is the direct owner of these shares. F7 · ownership.nature: EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. EPQ LLC, AMT PS directly owns 2,149,292 common shares. EPQ LLC, AMTB PS directly owns 3,394,948 common shares. EPQ LLC, AMTC PS directly owns 2,500,000 common shares. Chad Boeding directly owns 220,000 common shares. F8 · ownership.nature: Each of EPIQ, the EPQ Funds, and Mr. Boeding disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.